{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:23:34Z","timestamp":1754151814449,"version":"3.41.2"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>We reported a patient with acute hepatitis E who had recurrent vomiting and dizziness that are uncommon in other patients with hepatitis E. The patient developed dizziness 1 month ago prior, accompanied by yellow urine, sclera, and staining of the skin. Half a month prior, the patient gradually developed fatigue and a poor appetite, accompanied by nausea, aversion to oil, loss of appetite, and itching of the skin. The patient turned out to have an acute hepatitis E infection and was hospitalized for more than a month with repeated vomiting and dizziness. He was treated conservatively with drugs for various reasons. After more than 1 month of medication and rest, the patient's vomiting and dizziness symptoms improved significantly, and follow-up found that the recovery was good.<\/jats:p>","DOI":"10.3389\/fmed.2025.1614921","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T05:22:24Z","timestamp":1753075344000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A patient with acute hepatitis E and intractable vomiting: a case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Kui","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jcv.2013.10.003","article-title":"Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients","volume":"58","author":"Abravanel","year":"2013","journal-title":"J Clin Virol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/jcm9020331","article-title":"Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections","volume":"9","author":"Lhomme","year":"2020","journal-title":"J Clin Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.cnur.2020.07.001","article-title":"Efficacy of acupuncture\/acupressure in the prevention and treatment of nausea and vomiting across multiple patient populations: implications for practice","volume":"55","author":"Morehead","year":"2020","journal-title":"J Nurs Clin North Am"},{"key":"B4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/MCG.0000000000001485","article-title":"Nausea and vomiting in 2021: a comprehensive update","volume":"55","author":"Heckroth","year":"2021","journal-title":"J Clin Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/gut.2005.065318","article-title":"Toll-like receptors 2 and 4 are differentially involved in Fas dependent apoptosis in Peyer's patch and the liver at an early stage after bile duct ligation in mice","volume":"55","author":"Ogawa","year":"2006","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.3748\/wjg.v26.i37.5543","article-title":"Hepatitis E virus: epidemiology, diagnosis, clinical manifestations, and treatment","volume":"26","author":"Aslan","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"Van Doorn","year":"2008","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jhep.2016.11.016","article-title":"Hepatitis E virus: infection beyond the liver?","volume":"66","author":"Pischke","year":"2017","journal-title":"J Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/jvh.12515","article-title":"Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells","volume":"23","author":"Drave","year":"2016","journal-title":"J Viral Hepat"},{"key":"B11","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/jvh.12557","article-title":"Evidence of hepatitis E virus breaking through the blood-brain barrier and replicating in the central nervous system","volume":"23","author":"Shi","year":"2016","journal-title":"J Viral Hepat."},{"key":"B12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fcimb.2019.00433","article-title":"Hepatitis E virus induces brain injury probably associated with mitochondrial apoptosis","volume":"9","author":"Tian","year":"2019","journal-title":"Front Cell Infect Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"17086","DOI":"10.1038\/nrdp.2017.86","article-title":"Hepatitis E virus infection","volume":"3","author":"Kamar","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"B14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3201\/eid1905.121845","article-title":"World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA","volume":"19","author":"Baylis","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jhep.2011.01.009","article-title":"Acute autochthonous hepatitis E in Western patients with underlying chronic liver disease: a role for ribavirin?","volume":"54","author":"P\u00e9ron","year":"2011","journal-title":"J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/liv.12114","article-title":"Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience","volume":"33","author":"Pischke","year":"2013","journal-title":"Liver Int."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1614921\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T05:22:25Z","timestamp":1753075345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1614921\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":16,"alternative-id":["10.3389\/fmed.2025.1614921"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1614921","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"article-number":"1614921"}}